DN

dNovo

YC S18

San Francisco, US · Founded 2018 · 4 employees · Inactive · 2 known investors

dnovobio.com ↗

dNovo develops direct reprogramming technology to convert skin, blood, or fat cells into new stem cells, targeting age-related stem cell depletion. The company aims to address aging through cellular regeneration for consumers.

Founders & leadership· Y Combinator alumni (S18)

EL

Ernesto LujaninFounder

Investors · 2

FL

Flucas VenturesJupiter · $100K – $5Mvia Ashley Flucas · inferred

Y

Y CombinatorSan Francisco · $500K

Competitors · 1

by search overlap

NO

Novo Nordisk3 shared keywordsNovo Nordisk is a pharmaceutical company that develops and markets treatments for diabetes, hemophilia, weight management, and other chronic diseases through innovative drug therapies.

Companies competing with dNovo for the same Google search keywords, organic and paid, via search-intersection analysis.